IC Market Espresso 31 May 2019

 
Ericsson NT Signes Two-Year Agreement Worth HRK 34m

To put things into a perspective, this would amount to 2.1% of the company’s 2018 consolidated sales.

Ericsson Nikola Tesla published a document in which they state that they have signed a two-year frame agreement with the government, related to the services of maintaining the Joint Information System of Land Registry and Cadaster (JIS).

The agreement relates to the following services: basic maintenance of JIS, adaptive and perfective maintenance of JIS, special services and support of the digital geodetic technical report. Note that the contract is worth more than HRK 34m. To put things into a perspective, this would amount to 2.1% of the company’s 2018 consolidated sales.

To read about the company’s Q1 2019 results click here.

Sopharma Q1 2019 Results

In Q1, the company recorded an increase in sales of 7%, increase in EBITDA of 12.4% and an increase in net income of 26.2%.

As Sopharma published their Q1 2019 report, we are bringing you key takes from it. According to the report, the company observed sales of BGN 313.3m, representing an increase of 7% YoY.

Sales of goods increased by BGN 10.3m or 4%, reaching BGN 248.4m. Of that, Tablets amounted to BGN 121.7m, which represents an increase of 1% YoY. Meanwhile, sales of finished products increased by BGN 10.2m, or 19%, to BGN 64.9m. Of that, Tablets amounted to BGN 44m, which represents an increase of 25% YoY.

When observing the revenues by market, Bulgaria accounted for 65%, representing an increase of 7%. Europe as a market made up for 34% of the company’s sales, representing also an increase of 7%.

In Q1, Operating expenses increased by BGN 20.6m (+7%) to BGN 298.8m. The change is a consequence of the growth of sales and, respectively, of the increase of material expenses, hired services, personnel costs, amortization and other operating expenses.

Going further down the P&L, EBITDA observed an increase of 12.4%, amounting to BGN 28.1m

When observing the net financial result, the company reduced their net financial loss from BGN 1.3m to BGN 0.8m.

In Q1, Sopharma recorded an increase in net income of 26.2%, amounting to BGN 17.2m.

Performance (Q1 2019 vs Q1 2018) (BGN m)